Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity

Provided By Globe Newswire

Last update: Apr 11, 2022

– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan indication with strong unmet medical need